HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yunyan Wu Selected Research

Basic Helix-Loop-Helix Transcription Factors

1/2017DEC1 negatively regulates the expression of CXCL10 and CCL5 induced by poly IC in normal human mesangial cells.
12/2016Basic helix-loop-helix transcription factor DEC2 functions as an anti-apoptotic factor during paclitaxel-induced apoptosis in human prostate cancer cells.
6/2016Podoplanin-mediated TGF-β-induced epithelial-mesenchymal transition and its correlation with bHLH transcription factor DEC in TE-11 cells.
3/2015Involvement of c-Myc in the proliferation of MCF-7 human breast cancer cells induced by bHLH transcription factor DEC2.
1/2015Basic helix-loop-helix transcription factor DEC1 regulates the cisplatin-induced apoptotic pathway of human esophageal cancer cells.
10/2012The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer.
9/2012The basic helix-loop-helix transcription factor DEC2 inhibits TGF-β-induced tumor progression in human pancreatic cancer BxPC-3 cells.
4/2012BHLH transcription factor DEC2 regulates pro-apoptotic factor Bim in human oral cancer HSC-3 cells.
4/2011Basic helix-loop-helix transcription factors DEC1 and DEC2 regulate the paclitaxel-induced apoptotic pathway of MCF-7 human breast cancer cells.
4/2010Anti-apoptotic effect of the basic helix-loop-helix (bHLH) transcription factor DEC2 in human breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yunyan Wu Research Topics

Disease

19Neoplasms (Cancer)
02/2022 - 10/2010
9Hypoxia (Hypoxemia)
07/2017 - 04/2010
8Breast Neoplasms (Breast Cancer)
10/2020 - 04/2010
5Esophageal Squamous Cell Carcinoma
12/2021 - 06/2016
4Melanoma (Melanoma, Malignant)
02/2020 - 01/2017
4Carcinoma (Carcinomatosis)
01/2020 - 04/2013
4Esophageal Neoplasms (Esophageal Cancer)
01/2020 - 01/2015
3Testicular Neoplasms (Testicular Cancer)
01/2020 - 06/2017
3Prostatic Neoplasms (Prostate Cancer)
10/2018 - 04/2014
2Neoplasm Metastasis (Metastasis)
01/2020 - 07/2019
2Stomach Neoplasms (Stomach Cancer)
09/2018 - 01/2017
2Pancreatic Neoplasms (Pancreatic Cancer)
10/2012 - 09/2012
2Mouth Neoplasms (Oral Cancer)
04/2012 - 07/2011
1Lung Neoplasms (Lung Cancer)
02/2020
1Rectal Neoplasms (Rectal Cancer)
12/2019
1Lymphatic Metastasis
07/2019
1Virus Diseases (Viral Diseases)
10/2018
1Colorectal Neoplasms (Colorectal Cancer)
05/2018
1Carcinogenesis
07/2017
1Hepatocellular Carcinoma (Hepatoma)
01/2017
1Fibroma (Fibromatosis)
05/2016
1Medullary Carcinoma
01/2016
1Neuroendocrine Carcinoma
01/2016
1Adenocarcinoma
01/2016
1Neoplasms, Cystic, Mucinous, and Serous
04/2013
1Pancreatic Intraductal Neoplasms
04/2013

Drug/Important Bio-Agent (IBA)

10Basic Helix-Loop-Helix Transcription FactorsIBA
01/2017 - 04/2010
6AntigensIBA
10/2020 - 06/2017
4Cisplatin (Platino)FDA LinkGeneric
12/2021 - 07/2011
3MethyltransferasesIBA
02/2020 - 07/2017
3Proteins (Proteins, Gene)FDA Link
02/2020 - 03/2015
2Peptides (Polypeptides)IBA
10/2020 - 07/2017
2DecitabineFDA Link
02/2020 - 01/2020
2Pharmaceutical PreparationsIBA
02/2020 - 07/2011
2A-Form DNA (A-DNA)IBA
02/2020 - 07/2017
2Biomarkers (Surrogate Marker)IBA
07/2019 - 01/2017
2Transforming Growth Factors (Transforming Growth Factor)IBA
10/2018 - 09/2012
2Paclitaxel (Taxol)FDA LinkGeneric
12/2016 - 04/2011
2Membrane Proteins (Integral Membrane Proteins)IBA
04/2013 - 10/2010
2Small Interfering RNA (siRNA)IBA
09/2012 - 10/2010
1Circular RNAIBA
02/2022
1Monoclonal AntibodiesIBA
10/2020
1Neoplasm Antigens (Tumor Antigens)IBA
02/2020
1qigesanIBA
01/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Keratins (Keratin)IBA
12/2019
1Transcription Factors (Transcription Factor)IBA
07/2019
1AntibodiesIBA
10/2018
1Factor VIII (Coagulation Factor VIII)IBA
09/2018
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
05/2018
1DesminIBA
05/2018
1CollagenIBA
05/2018
1Histones (Histone)IBA
01/2018
1Melanoma-Specific AntigensIBA
01/2018
1Eosine Yellowish-(YS) (Eosin)IBA
07/2017
1Hematoxylin (Haematoxylon)IBA
07/2017
1pyrimidin-2-one beta-ribofuranosideIBA
07/2017
1Cadherins (E-Cadherin)IBA
01/2017
1Formaldehyde (Formol)FDA Link
01/2017
1ParaffinIBA
01/2017
1Poly I-CIBA
01/2017
1Double-Stranded RNA (RNA, Double Stranded)IBA
01/2017
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2017
1Trastuzumab (Herceptin)FDA Link
01/2017
1human ERBB2 proteinIBA
01/2017
1GadoliniumIBA
05/2016
1Fetal Proteins (Fetoprotein)IBA
01/2016
1TE 5IBA
01/2015
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2014
1Epithelial Cell Adhesion MoleculeIBA
04/2013
1Claudin-4IBA
10/2012
1Claudin-1IBA
10/2010
1TamoxifenFDA LinkGeneric
10/2010

Therapy/Procedure

4Immunotherapy
10/2020 - 07/2017
2Therapeutics
10/2020 - 07/2017
2Neoadjuvant Therapy
12/2019 - 05/2016
1Drug Therapy (Chemotherapy)
12/2021
1Microspheres (Microsphere)
10/2018
1Adjuvant Chemotherapy
01/2017